Catalyst Wire Dossier Catalyst Wire Dossier

Gemcitabine

Gemcitabine · Hospira, Inc.
Drug timelines are a Plus or Pro feature.

1050 regulatory and trial events tracked for Gemcitabine, covering 2006-06-29 to 2026-08-24. Get the full timeline:

Most recent: Clinical Trial Results: Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer [Phase 2]

See pricing